Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27


Development and validation of the Salzburg COPD-screening questionnaire (SCSQ): a questionnaire development and validation study.

Weiss G, Steinacher I, Lamprecht B, Kaiser B, Mikes R, Sator L, Hartl S, Wagner H, Studnicka M.

NPJ Prim Care Respir Med. 2017 Jan 26;27(1):4. doi: 10.1038/s41533-016-0005-7.


Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawal.

Yawn BP, Suissa S, Rossi A.

NPJ Prim Care Respir Med. 2016 Sep 29;26:16068. doi: 10.1038/npjpcrm.2016.68. Review.


Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective.

Babu KS, Kastelik JA, Morjaria JB.

Br J Clin Pharmacol. 2014 Aug;78(2):282-300. doi: 10.1111/bcp.12334. Review.


Chronic obstructive pulmonary disease lost in translation: Why are the inhaled corticosteroids skeptics refusing to go?

Ai-Kassimi FA, Alhamad EH.

Ann Thorac Med. 2013 Jan;8(1):8-13. doi: 10.4103/1817-1737.105711.


Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Nannini LJ, Lasserson TJ, Poole P.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD006829. doi: 10.1002/14651858.CD006829.pub2. Review.


Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodules.

Veronesi G, Szabo E, Decensi A, Guerrieri-Gonzaga A, Bellomi M, Radice D, Ferretti S, Pelosi G, Lazzeroni M, Serrano D, Lippman SM, Spaggiari L, Nardi-Pantoli A, Harari S, Varricchio C, Bonanni B.

Cancer Prev Res (Phila). 2011 Jan;4(1):34-42. doi: 10.1158/1940-6207.CAPR-10-0182. Epub 2010 Dec 16.


Influencing the decline of lung function in COPD: use of pharmacotherapy.

Gladysheva ES, Malhotra A, Owens RL.

Int J Chron Obstruct Pulmon Dis. 2010 Jun 3;5:153-64. Review.


Defining disease modification in chronic obstructive pulmonary disease.

Halpin DM, Tashkin DP.

COPD. 2009 Jun;6(3):211-25. Review.


Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT studies.

Miravitlles M, Anzueto A.

Int J Chron Obstruct Pulmon Dis. 2009;4:185-201. Epub 2009 May 7. Review.



Kerstjens HA, Postma DS, Ten Hacken N.

BMJ Clin Evid. 2008 Dec 15;2008. pii: 1502. Review.


One-year treatment with mometasone furoate in chronic obstructive pulmonary disease.

Calverley PM, Rennard S, Nelson HS, Karpel JP, Abbate EH, Stryszak P, Staudinger H.

Respir Res. 2008 Nov 13;9:73. doi: 10.1186/1465-9921-9-73.


Effect of COPD treatments on MRP1-mediated transport in bronchial epithelial cells.

van der Deen M, Homan S, Timmer-Bosscha H, Scheper RJ, Timens W, Postma DS, de Vries EG.

Int J Chron Obstruct Pulmon Dis. 2008;3(3):469-75.


COPD: what is the unmet need?

Calverley PM.

Br J Pharmacol. 2008 Oct;155(4):487-93. doi: 10.1038/bjp.2008.362. Epub 2008 Sep 15. Review.


Role of tiotropium in the treatment of COPD.

Rice KL, Kunisaki KM, Niewoehner DE.

Int J Chron Obstruct Pulmon Dis. 2007;2(2):95-105. Review.


The combination of tiotropium and budesonide in the treatment of chronic obstructive pulmonary disease.

Um SW, Yoo CG, Kim YW, Han SK, Shim YS.

J Korean Med Sci. 2007 Oct;22(5):839-45.


Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease.

Nannini L, Cates CJ, Lasserson TJ, Poole P.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003794. Review. Update in: Cochrane Database Syst Rev. 2013;11:CD003794.


Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD.

Grootendorst DC, Gauw SA, Verhoosel RM, Sterk PJ, Hospers JJ, Bredenbröker D, Bethke TD, Hiemstra PS, Rabe KF.

Thorax. 2007 Dec;62(12):1081-7. Epub 2007 Jun 15.


Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD.

Salpeter SR, Buckley NS, Salpeter EE.

J Gen Intern Med. 2006 Oct;21(10):1011-9. Erratum in: J Gen Intern Med. 2006 Oct;21(10):1131.

Supplemental Content

Support Center